Zafgen is a biopharmaceutical company dedicated to significantly improving the
health and well-being of patients affected by metabolic diseases including type 2 diabetes and obesity.
Nov 09, 2016
Sep 20, 2016
Aug 04, 2016
Jul 19, 2016
Jun 13, 2016
Jun 01, 2016
We're looking at — and targeting — metabolic diseases in a totally different way
A steady flow of new scientific evidence continues to reveal insights into the breadth of benefits that can be derived from targeting MetAP2, Zafgen’s focus for new therapeutic development.
Learn More »